Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Erin E. Heyer
Observed names:
Erin E Heyer,
Erin Heyer,
Erin E. Heyer,
Heyer, Erin,
Heyer, Erin E.
Observed institutions:
Harvey Mudd College,
Howard Hughes Medical Institute,
Garvan Institute of Medical Research,
University of Massachusetts Chan Medical School,
UNSW Sydney,
The Kinghorn Cancer Centre
show all 6
ORCID:
0000-0003-3426-9350
Observed ORCID:
0000-0003-3426-9350
OpenAlex ID:
A5082915656
Diagnosis of fusion genes using targeted RNA sequencing
2019
·
Erin E. Heyer
, Ira W. Deveson
, et al.
·
Nature Communications
·
239
PDF
Redefining the Translational Status of 80S Monosomes
2016
·
Erin E. Heyer
, Melissa J. Moore
·
Cell
·
214
PDF
Staufen1 senses overall transcript secondary structure to regulate translation
2013
·
Emiliano P Ricci
, Alper Kucukural
, et al.
·
Nature Structural & Molecular Biology
·
129
Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants
2021
·
Adam M. Bournazos
, Lisa G. Riley
, et al.
·
Genetics in Medicine
·
97
An optimized kit-free method for making strand-specific deep sequencing libraries from RNA fragments
2014
·
Erin E. Heyer
, Hakan Ozadam
, et al.
·
Nucleic Acids Research
·
59
PDF
Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors
2019
·
Toby Trahair
, Andrew J. Gifford
, et al.
·
JCO Precision Oncology
·
51
TMPRSS2‐ERG fusions linked to prostate cancer racial health disparities: A focus on Africa
2019
·
James Blackburn
, Stefano Vecchiarelli
, et al.
·
The Prostate
·
43
PDF
Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
2017
·
Emmy D.G. Fleuren
, Myrella Vlenterie
, et al.
·
Cancer Research
·
36
PDF
Sequencing Strategies for Fusion Gene Detection
2020
·
Erin E. Heyer
, James Blackburn
·
BioEssays
·
31
Genomic Therapy Matching in Rare and Refractory Cancers
2026
·
Frank P. Lin
, Subotheni Thavaneswaran
, et al.
·
JAMA Oncology
·
8
PDF
Identification and Characterization of Dynein Genes in Tetrahymena
2009
·
David E. Wilkes
, Nicole Bennardo
, et al.
·
Methods in cell biology
·
6
Author Correction: Diagnosis of fusion genes using targeted RNA sequencing
2020
·
Erin E. Heyer
, Ira W. Deveson
, et al.
·
Nature Communications
·
2
PDF
Improving sarcoma classification by using RNA hybridisation capture sequencing in sarcomas of uncertain histogenesis of young individuals
2023
·
Ana Cristina Vargas
, Erin E. Heyer
, et al.
·
Pathology
·
1
PDF
Abstract 4824: Targeting CD30 as a novel treatment strategy in RANBP2-ALK -rearranged inflammatory myofibroblastic tumor
2019
·
Ashleigh M. Fordham
, James Blackburn
, et al.
·
Cancer Research
·
1
Supplemental Table 5 from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
2023
·
Emmy D.G. Fleuren
, Myrella Vlenterie
, et al.
Supplemental Table 4 from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
2023
·
Emmy D.G. Fleuren
, Myrella Vlenterie
, et al.
Supplementary Tables 1-3 and Figures 1-9 from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
2023
·
Emmy D.G. Fleuren
, Myrella Vlenterie
, et al.
Data from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
2023
·
Emmy D.G. Fleuren
, Myrella Vlenterie
, et al.
Supplementary Tables 1-3 and Figures 1-9 from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
2023
·
Emmy D.G. Fleuren
, Myrella Vlenterie
, et al.
PDF
Supplemental Table 5 from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
2023
·
Emmy D.G. Fleuren
, Myrella Vlenterie
, et al.
Supplemental Table 4 from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
2023
·
Emmy D.G. Fleuren
, Myrella Vlenterie
, et al.
Data from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
2023
·
Emmy D.G. Fleuren
, Myrella Vlenterie
, et al.
778.RNAseq.NormCoverage.DESeq2.forward.bw
2022
·
Heyer, Erin
·
Figshare
Abstract 4824: Targeting CD30 as a novel treatment strategy inRANBP2-ALK-rearranged inflammatory myofibroblastic tumor
2019
·
Ashleigh M. Fordham
, James Blackburn
, et al.
·
Experimental and Molecular Therapeutics
Optimizing RNA Library Preparation to Redefine the Translational Status of 80S Monosomes: A Dissertation
2015
·
Heyer, Erin E.
·
The Journal of the American Medical Association (JAMA) Network (American Medical Association)
Show more works
View as search
Works count:
25
Citation count:
917
H-index:
9
I10-index:
9
Year
Topic
Type
